A new cure for the metabolic syndrome (obesity, diabetes, hypertension) is going to develop British scientists from the University of Buckingham (University of Buckingham). According to The Telegraph, hemp leaves will be the basis of the new medicine.

The thing is that in the course of research, scientists found useful compounds in the hemp leaves - tetrahydrocannabivarine and cannabidiol, which contribute to a significant increase in energy consumption by the human body and a serious decrease in appetite.

Moreover, these compounds, the researchers found out with a more thorough study of cannabis leaves, affect the level of fat in the human body and the body's response to insulin.

Therefore, Professor Mike Cawthorne is confident that hemp medicine can significantly help in the treatment of type 2 diabetes, as it lowers blood cholesterol and fat in organs such as the liver that are vital for humans.. Animal Testing Successful. The medicine is currently undergoing clinical trials in 200 patients..

According to Stef Wright, Director of Research and Development, British pharmaceutical company GW Pharmaceuticals, by the end of the year a new drug for the metabolic syndrome will be received. Researchers are now particularly carefully monitoring how this drug affects the distribution of fat in the human body..

Recall that GW Pharmaceuticals is licensed to grow 20 tons of hemp for medical research in large industrial greenhouses in the south of England annually.

In addition to obesity, diabetes, and arterial hypertension, cannabis medicines suggest that epileptics and people with multiple sclerosis can be treated.. In the course of studies, hemp leaves found compounds that affect the frequency of epileptic seizures and improve the condition of patients with multiple sclerosis. These medicines are already under development..

Text:.

Orlov.

EUROSMI. RU.